Member Info for Newuncle

Our proprietary patented platform, a bioabsorbable self-nanoemulsifying drug delivery system (SNEDDS), represents a cutting-edge solution in drug delivery technology

OH more you post then so do I keep em coming

🚀🚀🚀🚀Keep it coming OH, luvin the free PR on LSE, now everyone is aware of GPL, thank you

🚀🚀🚀Keep it coming Open H

The more open heimer posts the better imo free PR on LSE, luvin it

Recent Patent Filings

The Company continues to develop its intellectual property portfolio, supporting its focus on the healthcare industry clients and targeting SNEDDS-related commercial collaboration opportunities. Recently, the Company submitted two utility patent applications (provisional) to the United States Patent and Trademark Office (USPTO) for using its SNEDDS platform in drug delivery for substance use disorders and mental health treatment.

On 28 May 2024, the Company filed the first of these applications titled "Composition and Methods for Substance Use Disorders (SUDS) using a Self-Nanoemulsifying Drug Delivery System (SNEDDS)," covering the innovative application of its SNEDDS platform to enhance the bioavailability, pharmacokinetics, and stability of therapeutics used in treating substance use disorders.

On 31 May 2024, the Company filed the second provisional patent titled "Composition and Methods for Mental Health Disorders using a Self-Nanoemulsifying Drug Delivery System (SNEDDS)," covering the innovative application of our SNEDDS platform to enhance the bioavailability, pharmacokinetics, and stability of therapeutics used in treating mental health disorders such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD).

Operational review and focus on the future

The operational review referenced in the Company's announcement of 2 May 2024 has begun. The review is focused on the Company's healthcare industry orientated Graft Bio division which, in the Directors' opinion, has strong prospects through its:

🦾 intellectual property,

🦾licensing agreements, and

🦾sales contracts.

🦾Shareholders will be kept informed as details of the review emerge.

Anthony Tennyson, CEO, commented:

"The global emergency hemostasis products market is significant and growing, and the grant of this patent underscores the potential of our Graft Bio division. With our enhanced hemostasis IP portfolio, we are well-equipped to address the evolving needs of healthcare professionals and patients in this segment. Concurrently, we are actively pursuing our previously announced review of the Company's operations to identify additional opportunities for growth."

The Company is pleased to announce the grant of patent P-202400066, titled "Dual hydrogel multi-crosslinking haemostatic composition and method of manufacturing thereof", to further strengthen the Company's IP portfolio.

News coming soon

Strategic Significance

The filing of this patent follows the announcement, by the Company, on 28 May 2024 relating to the filing of a similar utility patent application (provisional) for the treatment of substance use disorders. It marks further progress in the Company's strategic focus on the healthcare industry, following the disposal of its industrial plastic manufacturing unit, Graft Polymer D.O.O, as announced on 3 May 2024. This disposal has enabled the Company to focus its attention and resources on its Graft Bio division, which represents, in the Directors' opinion, strong prospectivity through its intellectual property (IP), licensing agreements, and sales contracts.

News coming soon

News coming on those.....

Recent patent filings

Recently, the Group submitted two utility patent applications (provisional) to the United States Patent and Trademark Office for the use of its SNEDDS platform in drug delivery for substance use disorders and mental health treatment.

Actually OpenH, keep posting every post gets us more noticed so feel free

Reported False and Misleading

Reported false and misleading posts

Just report openheimer, I have, pointless engaging with one

Stfu earlofsyhte

I am actually embarrassed for you the toe, probably the worst attempted deramp I have seen here

TheToe try reading the rns

250k LOFL